SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694665-23-000134
Filing Date
2023-08-09
Accepted
2023-08-09 20:42:39
Documents
1
Period of Report
2023-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1691628149.html 4  
1 FORM 4 wk-form4_1691628149.xml 4 7977
  Complete submission text file 0001694665-23-000134.txt   9352
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
McHale Duncan (Reporting) CIK: 0001738896 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 231156895